Tenofovir is a more suitable treatment than entecavir for chronic hepatitis B patients carrying naturally occurring rtM204I mutations

BACKGROUND: Hepatitis B virus (HBV) DNA polymerase mutations usually occur to long term use of nucleos(t)ide analogues (NAs), but they can occur spontaneously in treatment-naïve chronic hepatitis B (CHB) patients. The naturally occurring HBV DNA polymerase mutations might complicate antiviral therap...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:World J Gastroenterol
Hlavní autoři: Choe, Won Hyeok, Kim, Kijeong, Lee, So-Young, Choi, Yu-Min, Kwon, So Young, Kim, Jeong Han, Kim, Bum-Joon
Médium: Artigo
Jazyk:Inglês
Vydáno: Baishideng Publishing Group Inc 2019
Témata:
Observational Study
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6737324/
https://ncbi.nlm.nih.gov/pubmed/31543688
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v25.i33.4985
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky